Close Menu

NEW YORK ─ Ortho Clinical Diagnostics said on Wednesday that it anticipates the award of a $53.7 million US government agency contract to support a more than threefold increase in US production of its COVID-19 antibody and antigen diagnostic tests.

The US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) and the US Department of Defense (DoD) have awarded Ortho an undefinitized contract that will lead to the $53.7 million award under a separate contract to accelerate test production, the Raritan, New Jersey-based company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.